TIDMALGW
RNS Number : 3341Z
Alpha Growth PLC
15 May 2023
Alpha Growth plc
(" Alpha " or the "Company")
Acquisition of Minority Shareholding and Share Issuance
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading
financial services specialist in the growing longevity asset class
and insurance linked asset management, announces that it has
entered into an agreement to purchase the outstanding 5% minority
shareholding (the " Minority Stake" ) it did not own in Northstar
Group (Bermuda) Limited (" Northstar" ), the Company's Bermuda
based insurance holding company, for a total consideration of
GBP330,102.
As announced on 11 February 2021, Alpha's wholly-owned
subsidiary Alpha Group (Bermuda) Ltd acquired 95% of Northstar,
with the Minority Stake being retained by Northstar's original
founder, Daniel Gray who subsequently joined and continues to be a
board member of Providence Life Assurance Company (Bermuda) Ltd and
Alpha International Life Assurance Company (Guernsey) Ltd. The
Company has now acquired the Minority Stake and Northstar is
therefore a wholly owned group company.
The consideration due for the acquisition of the Minority Stake
has been settled by Alpha issuing 12,696,231 ordinary shares of
0.1p each (" Ordinary Shares ") at a deemed issued price of 2.6p
per Ordinary Share.
In addition, the Company has issued 3,265,306 Ordinary Shares to
Jason Sutherland (Executive Director) in lieu of GBP80,000 in
director's fees owed to him, of which GBP72,000 relates to the
period to 31 December 2022 and which have been reported in the
recently published financial statements to that date. The deemed
issue price was 2.45p per Ordinary Share, which was the closing
price of the Ordinary Shares on 31 December 2022.
Application has been made for a total of 15,961,537 Ordinary
Shares to be admitted to the standard listing segment of the
Official List of the Financial Conduct Authority and to be admitted
to trading on the main market for listed securities of the London
Stock Exchange plc (together, " Admission" ). Admission is expected
to become effective at 8.00 a.m. on 16 May 2023.
Gobind Sahney, Executive Chairman, commented: "I am very pleased
that we were able to complete the 100% ownership of Northstar and
that we get the continued alignment of interest with Dan, who
continues to be a valued advisor to the group in the growth of its
life insurance business, now as a direct shareholder in Alpha."
Total Voting Rights
On Admission, the Company's issued share capital will consist of
467,775,068 Ordinary Shares. There are no Ordinary Shares held in
treasury. Accordingly, the total number of vo ti ng rights in Alpha
Growth plc at Admission will be 467,775,068.
The above figure 467,775,068 may be used by shareholders as the
denominator for the calcula ti ons by which they will determine if
they are required to notify their interest in, or a change to their
interest in, Alpha Growth plc under the FCA's Disclosure Guidance
and Transparency Rules.
**S **
For more information, please visit www.algwplc.com or contact
the following:
+44 (0) 20 3959
Alpha Growth plc 8600
Gobind Sahney, Executive Chairman info@algwplc.com
+44 (0) 20 3328
Allenby Capital Limited 5656
Amrit Nahal (Sales and Corporate Broking)
Nick Athanas / Piers Shimwell (Corporate
Finance)
UK Investor Relations - Mark Treharne ir@algwplc.com
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing
specialist consultancy, advisory, and supplementary services to
institutional and qualified investors globally in the multi-billion
dollar market of longevity assets. Building on its well-established
network, the Alpha Growth group has a unique position in the
longevity asset services and investment business, as a listed
entity with global reach. The group's strategy is to expand its
advisory and business services via acquisitions and joint ventures
in the UK and the US to attain commercial scale and provide
holistic solutions to alternative institutional investors who are
in need of specialised skills and unique access to deploy their
financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate,
equity capital and commodity markets. Its value is a function of
time because as time passes the value gets closer to the face value
of the policy. Hence creating a steady increase in the net asset
value of the investment. This makes it highly attractive to
investors wishing to counteract volatility within an investment
portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets
that originate in the USA where the structured and life settlement
market is highly regulated.
Forward Looking Statements Disclaimer
Certain statements, beliefs and opinions in this document are
forward-looking, which reflect the Company's or, as appropriate,
the Company's directors' current expectations and projections about
future events. By their nature, forward-looking statements involve
a number of risks, uncertainties and assumptions that could cause
actual results or events to differ materially from those expressed
or implied by the forward-looking statements. These risks,
uncertainties and assumptions could adversely affect the outcome
and financial effects of the plans and events described herein.
Forward-looking statements contained in this document regarding
past trends or activities should not be taken as a representation
that such trends or activities will continue in the future. The
Company does not undertake any obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. You should not place undue reliance on
forward- looking statements, which speak only as of the date of
this document. Readers should not treat the contents of this
document as advice relating to legal, taxation or investment
matters, and are to make their own assessments concerning these and
other consequences, including the merits of information and the
risks. Readers of this announcement are advised to conduct their
own due diligence and agree to be bound by the limitations of this
disclaimer.
Important Notice
The content of this announcement has not been approved by an
authorised person within the meaning of the Financial Services and
Markets Act 2000 (FSMA). This announcement has been issued by and
is the sole responsibility of the Company. The information in this
announcement is subject to change.
Details of the transactions can be found in the Notification of
Dealing Form below.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Jason Sutherland
-------------------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------------------
a) Position/status PDMR
-------------------------------------- ------------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------------
a) Name Alpha Growth plc
-------------------------------------- ------------------------------------------
b) LEI
213800T46KFT32KYKR91
-------------------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------------
a) Description of the Ordinary Shares of 0.1pence each
financial instrument,
type of instrument
Identification code GB00BYWKBC49
b) Nature of the transaction Issue of Ordinary Shares in lieu of
director's fees
-------------------------------------- ------------------------------------------
c) Price(s) and volume(s)
------------------- ------------------
Price(s) Volume(s)
------------------- ------------------
GBP0.0245 3,265,306
--------------------------------------------------------------- ------------------
d) Aggregated information N/A - Single transaction
- Aggregated volume
- Price
e) Date of the transaction 16 May 2023
-------------------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
-------------------------------------- ------------------------------------------
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBBGDULUBDGXX
(END) Dow Jones Newswires
May 15, 2023 02:00 ET (06:00 GMT)
Alpha Growth (LSE:ALGW)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Alpha Growth (LSE:ALGW)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
